Sandbox:DD HA: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 28: | Line 28: | ||
* Jaundice | * Jaundice | ||
| | | | ||
* Removal of offending agent | |||
* Steroids | |||
* Alternative immunosuppression | |||
| | | | ||
|- | |- | ||
Line 50: | Line 53: | ||
* Weakness | * Weakness | ||
| | | | ||
* Removal of offending medication | |||
* High-dose vitamin B6 (up to 200mg daily) | |||
* Avoidance of splenectomy | |||
* Symptomatic transfusion support with iron chelation as needed | |||
| | | | ||
|- | |- | ||
Line 68: | Line 75: | ||
* Elevated ferritin | * Elevated ferritin | ||
| | | | ||
* Pallor | |||
* Weakness | |||
| | | | ||
* Treatment of the underlying cause; erythropoiesis-stimulating agents | |||
* Supportive red blood cell transfusions | |||
| | | | ||
|- | |- | ||
Line 79: | Line 91: | ||
* Abnormal hemoglobin electrophoresis (in beta-thalassemia) | * Abnormal hemoglobin electrophoresis (in beta-thalassemia) | ||
| | | | ||
* Irritability | |||
* Growth retardation | |||
* Jaundice | |||
* Hepatomegaly | |||
* Splenomegaly | |||
| | | | ||
* Transfusion support | |||
* Iron chelation | |||
* Gene therapy if available | |||
| | | | ||
|- | |- | ||
Line 93: | Line 113: | ||
* Low ferritin | * Low ferritin | ||
| | | | ||
* Pallor | |||
* Weakness | |||
* Positive occult blood testing (if GI bleeding) | |||
| | | | ||
* Intravenous or oral iron supplementation | |||
| | | | ||
|- | |- | ||
Line 104: | Line 130: | ||
* Low erythropoietin level | * Low erythropoietin level | ||
| | | | ||
* Pallor | |||
* Weakness | |||
* Signs of chronic kidney disease | |||
| | | | ||
* Epoetin alfa 50-100 units/kg 3 times weekly | |||
* Darbepoietin 0.45 mcg/kg weekly or 0.75 mcg/kg every 2 weeks | |||
| | | | ||
|- | |- | ||
Line 119: | Line 150: | ||
* Megaloblastic anemia with hypersegmented neutrophils | * Megaloblastic anemia with hypersegmented neutrophils | ||
| | | | ||
* Numbness | |||
* Weakness | |||
* Tingling | |||
* Paresthesias | |||
| | | | ||
* Vitamin B12 1000mcg daily | |||
* Folate 1mg daily | |||
| | | | ||
|} | |} |
Revision as of 20:11, 31 October 2017
DD of hemolytic anemia
Characterisitc/Parameter | Etiology | Mean corpuscular volume | Laboratory abnormalities | Physical examination | Treatment | Other associated abnormalities |
---|---|---|---|---|---|---|
Hemolytic anemia |
|
|
|
|
|
|
Sideroblastic anemia |
|
Or
|
|
|
|
|
Anemia of chronic disease |
|
|
|
|
|
|
Thalassemia |
|
|
|
|
|
|
Iron deficiency anemia |
|
|
|
|
|
|
Erythropoietin deficiency |
|
|
|
|
|
|
Vitamin B12 or folate deficiency |
|
|
|
|
|